ATP-dependent Lon protease controls tumor bioenergetics by reprogramming mitochondrial activity.
Quirós Pedro M,Español Yaiza,Acín-Pérez Rebeca,Rodríguez Francisco,Bárcena Clea,Watanabe Kenta,Calvo Enrique,Loureiro Marta,Fernández-García M Soledad,Fueyo Antonio,Vázquez Jesús,Enríquez José Antonio,López-Otín Carlos
We generated mice deficient in Lon protease (LONP1), a major enzyme of the mitochondrial quality control machinery. Homozygous deletion of Lonp1 causes early embryonic lethality, whereas its haploinsufficiency protects against colorectal and skin tumors. Furthermore, LONP1 knockdown inhibits cellular proliferation and tumor and metastasis formation, whereas its overexpression increases tumorigenesis. Clinical studies indicate that high levels of LONP1 are a poor prognosis marker in human colorectal cancer and melanoma. Additionally, functional analyses show that LONP1 plays a key role in metabolic reprogramming by remodeling OXPHOS complexes and protecting against senescence. Our findings demonstrate the relevance of LONP1 for cellular and organismal viability and identify this protease as a central regulator of mitochondrial activity in oncogenesis.